Page last updated: 2024-10-24

positive regulation of circadian sleep/wake cycle, non-REM sleep

Definition

Target type: biologicalprocess

Any process that activates or increases the duration or quality of non-rapid eye movement (NREM) sleep. [GOC:go_curators]

The positive regulation of the circadian sleep/wake cycle, specifically non-REM sleep, is a complex biological process involving a coordinated interplay of various molecular mechanisms. It entails the enhancement or activation of cellular processes that promote the transition into and maintenance of non-REM sleep, aligning with the body's internal biological clock. This regulation encompasses a multitude of factors, including:

- **Circadian Rhythms:** The central circadian pacemaker, located in the suprachiasmatic nucleus (SCN) of the hypothalamus, generates a roughly 24-hour rhythm that influences sleep-wake cycles. The SCN receives light cues from the environment, synchronizing its output with the external day-night cycle. This rhythmic activity is transmitted to various peripheral oscillators throughout the body, influencing diverse physiological processes, including sleep regulation.

- **Neurotransmitter Signaling:** Neurotransmitters play a crucial role in the modulation of sleep. Key players include:
- **Melatonin:** Synthesized by the pineal gland, melatonin levels increase in the evening, promoting sleep onset and duration.
- **GABA:** A major inhibitory neurotransmitter in the brain, GABA promotes relaxation and sleepiness by reducing neuronal activity.
- **Serotonin:** Although known for its mood-regulating properties, serotonin also plays a role in sleep-wake regulation.
- **Histamine:** While histamine is associated with wakefulness, its suppression contributes to sleep initiation.

- **Hormonal Influences:** Hormones contribute to sleep regulation, with notable examples being:
- **Cortisol:** A stress hormone, cortisol levels typically peak in the morning, promoting wakefulness, and decline in the evening.
- **Growth Hormone:** Released during sleep, growth hormone plays a crucial role in tissue repair and development.

- **Sleep-Promoting Factors:** Specific sleep-promoting factors contribute to the initiation and maintenance of non-REM sleep, including:
- **Adenosine:** As neurons become active, adenosine accumulates in the brain, promoting sleepiness.
- **Prostaglandins:** These lipid molecules influence sleep regulation, with some promoting sleepiness.

- **Molecular Mechanisms:** At the molecular level, various signaling pathways and gene expression changes underlie the regulation of non-REM sleep. This includes the involvement of:
- **CLOCK and BMAL1:** These transcription factors drive the circadian clock, regulating the expression of other genes involved in sleep regulation.
- **PER and CRY:** These proteins feedback on CLOCK and BMAL1, modulating their activity and thus influencing circadian rhythms.

- **Homeostatic Regulation:** Sleep drive, reflecting the accumulated need for sleep, influences the duration and intensity of non-REM sleep. This drive is influenced by factors such as sleep deprivation and wakefulness duration.

Overall, the positive regulation of the circadian sleep/wake cycle, non-REM sleep, involves a complex interplay of neural, hormonal, and molecular mechanisms. This intricate system ensures that sleep occurs in a rhythmic manner, synchronized with the external environment, contributing to overall health and well-being.'
"

Proteins (1)

ProteinDefinitionTaxonomy
Melatonin receptor type 1BA melatonin receptor type 1B that is encoded in the genome of human. [PRO:WCB, UniProtKB:P49286]Homo sapiens (human)

Compounds (22)

CompoundDefinitionClassesRoles
melatoninacetamides;
tryptamines
anticonvulsant;
central nervous system depressant;
geroprotector;
hormone;
human metabolite;
immunological adjuvant;
mouse metabolite;
radical scavenger
methylbufotenin5-methoxy-N,N-dimethyltryptamine : A tryptamine alkaloid that is N,N-dimethyltryptamine substituted by a methoxy group at position 5.aromatic ether;
tertiary amino compound;
tryptamine alkaloid
hallucinogen;
plant metabolite
6-chloromelatoninacetamides
6-hydroxymelatonin6-hydroxymelatonin : A member of the class of tryptamines that is melatonin with a hydroxy group substituent at position 6.acetamides;
tryptamines
metabolite;
mouse metabolite
catechin(+)-catechin : The (+)-enantiomer of catechin and a polyphenolic antioxidant plant metabolite.

catechin : Members of the class of hydroxyflavan that have a flavan-3-ol skeleton and its substituted derivatives.

Catechin: An antioxidant flavonoid, occurring especially in woody plants as both (+)-catechin and (-)-epicatechin (cis) forms.

rac-catechin : A racemate comprising equimolar amounts of (+)- and (-)-catechin
catechinantioxidant;
plant metabolite
4,4'-bisphenol f4,4'-bisphenol F: RN given refers to parent cpd

bisphenol F : A bisphenol that is methane in which two of the hydrogens have been replaced by 4-hydroxyphenyl groups.
bisphenol;
diarylmethane
environmental food contaminant;
xenoestrogen
s20098acetamides
6-methoxy-2,3,4,9-tetrahydropyrido[3,4-b]indol-1-onebeta-carbolines
2-iodomelatoninacetamides
luzindoleluzindole : A member of the class of indoles that is tryptamine in which one of the amino hydrogens is replaced by an acetyl group while the hydrogen at position 2 is replaced by a benzyl group.

luzindole: melatonin receptor antagonist; structure given in first source
acetamides;
indoles
melatonin receptor antagonist
2-bromomelatonin2-bromomelatonin: structure given in first source
5-methoxyluzindole
ramelteonramelteon: melatonin MT1/MT2 receptor agonistindanes
ah 001AH 001: structure given in first source; a melatonin agonist
4-phenyl-2-propionamidotetraline4-phenyl-2-propionamidotetraline: melatonin receptor antagonist; structure in first sourcetetralins
2-phenylmelatoninphenylindole
iik7IIK7: structure in first source
5-methoxycarbonylamino-n-acetyltryptamine5-methoxycarbonylamino-N-acetyltryptamine: an mt1/MT2 receptor agonistacetamides
8-methoxy-2-propionamidotetralin8-methoxy-2-propionamidotetralin: enhances sperm hyperactivation via the MT1 receptortetralins
k 185
ucm 454
5-hydroxyethoxy-n-acetyltryptamine5-hydroxyethoxy-N-acetyltryptamine: structure in first source